<DOC>
	<DOC>NCT01656096</DOC>
	<brief_summary>The purpose of this study is to examine the benefit of renal sympathetic denervation in patients with mild refractory hypertension</brief_summary>
	<brief_title>Renal Sympathetic Denervation in Mild Refractory Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Refractory hypertension: 3 or more antihypertensive agents of different classes (including a diuretic) at optimal dosage without change in the 4 weeks preceding randomization Systolic blood pressure of 135149 and/or diastolic blood pressure of 9094 mmHg (ABPM mean daytime values) No change in blood pressure medication within 6 months after randomization Age 18 to 75 years Informed consent Blood pressure outside range mentioned above Renal, aortic or pelvic anatomy unsuited for renal sympathetic denervation Estimated glomerular filtration rate &lt;45 mL/min/1.73 mÂ² (modification of diet in renal disease formula) Unstable angina pectoris Myocardial infarction within 6 months prior to randomization Planned surgery or cardiovascular intervention within 6 months after randomization Severe heart valve disease Severe comorbidities with limited life expectancy Pregnancy Participation in another trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>